An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn